TC
IDIX

TFS Capital’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

TFS Capital’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-15,147
Closed -$365K – 1429
2014
Q2 		$365K Buy
+15,147
New +$158K 0.03% 763
2013
Q3 		– Sell
-74,315
Closed -$268K – 1812
2013
Q2 		$268K Buy
+74,315
New +$304K 0.01% 1195

TFS Capital's IDIX Position: Q3 2014 in Review

TFS Capital sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 15,147 shares — an estimated $365K sold.

TFS Capital first reported a position in IDIX in Q2 2013 and held it in 2 quarters. The position peaked at $365K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • TFS Capital reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • TFS Capital sold 15,147 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $365K.
  • TFS Capital first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • TFS Capital's IDENIX PHARMACEUTICALS INC position peaked at $365K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on TFS Capital's 13F filing for Q3 2014, filed 6 Nov 2014.